Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial
Article Details
Authors (14)
Isabelle Mahé
Assistance Publique–Hôpitaux de Paris (AP-HP), Hôpital Louis Mourier, Service de Médecine Interne, Colombes, France
Céline Chapelle
Service de Pharmacologie Clinique, CHU de Saint-Étienne, Saint-Étienne, France
Marc Righini
Division of Angiology and Hemostasis, Faculty of Medicine, Geneva University Hospitals, Geneva
Grégoire Le Gal
Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa
Frederikus A. Klok
Giancarlo Agnelli
Internal Vascular and Emergency Medicine Stroke Unit, University of Perugia, Perugia, Italy
Francis Cajfinger
F-CRIN INNOVTE Network, Saint-Étienne, France (I.M., F.C., P.M., S.L.).
Marie-Antoinette Sevestre
Service de Médecine Vasculaire, CHU Amiens, Unité INSERM Chimère UA-21, Amiens Cedex, France (M.-A.S.).
Philippe A. Grenier
Délégation à la recherche et à l’innovation, Hôpital Foch, Suresnes, France (P.A.G.).
Jérôme Alexandre
Francis Couturaud
Investigation Network on Venous Thrombo-Embolism–French Clinical Research Infrastructure Network, Saint-Étienne, France
Patrick Mismetti
Investigation Network on Venous Thrombo-Embolism–French Clinical Research Infrastructure Network, Saint-Étienne, France
Silvy Laporte
Investigation Network on Venous Thrombo-Embolism–French Clinical Research Infrastructure Network, Saint-Étienne, France
Jean Chidiac
Assistance Publique–Hôpitaux de Paris (AP-HP), Hôpital Louis Mourier, Service de Médecine Interne, Colombes, France